Persistence of immunotherapy survival effects of sipuleucel-T and relationship to postrandomization docetaxel use in phase III studies.
暂无分享,去创建一个
M. Fishman | L. Klotz | D. Petrylak | N. Dawson | T. Gardner | R. Flanigan | B. Curti | J. Whitmore | M. Frohlich | Y. Xu